Medtronic (MDT) was upgraded by Credit Suisse (CS) to outperform from neutral as the firm believes that growth at the company should exceed that of consensus estimates during the next few quarters. Shares are higher by about three percent.
Thanks for checking us out. Please take a look at the rest of our videos and articles.
To stay in the loop, bookmark our homepage.